BiotechTube
Home/Eliksa Therapeutics/Jane Hollingsworth
JH

Jane Hollingsworth

Co-Founder & Executive Chairman

Eliksa Therapeutics

Therapeutic Areas

Rare DiseasesOphthalmologyDermatology

Eliksa Therapeutics Pipeline

DrugIndicationPhase
ELK-003Ocular manifestations of Epidermolysis Bullosa (EB)Pre-clinical/Early Clinical

Leadership Team at Eliksa Therapeutics

AK
Armen Karamanian, MD, PhD
Co-Founder & CEO
GV
Garrett Vygantas, MD
Board Member
View full Eliksa Therapeutics profile